AERPIO PHARMACEUTICALS, INC.

Company

Whitehawk Therapeutics, Inc.

Filed

June 4, 2021

Accession Number

0000902664-21-003006

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →